Laureillard D - Search Results

1

Efavirenz replacement by immediate full-dose nevirapine is safe in HIV-1-infected patients in Cambodia.

Laureillard D, Prak N, Fernandez M, Ngeth C, Moeung S, Riel V, Chhneang V, Song S, Quillet C, Piketty C. Laureillard D, et al. HIV Med. 2008 Aug;9(7):514-8. doi: 10.1111/j.1468-1293.2008.00597.x. Epub 2008 Jun 28. HIV Med. 2008. PMID: 18554312 Free article.

2

High performance of systematic combined urine LAM test and sputum Xpert MTB/RIF® for tuberculosis screening in severely immunosuppressed ambulatory adults with HIV.

Bonnet M, Gabillard D, Domoua S, Muzoora C, Messou E, Sovannarith S, Nguyen DB, Badje A, Juchet S, Bunnet D, Borand L, Natukunda N, Tran TH, Anglaret X, Laureillard D, Blanc FX; STATIS ANRS 12290 Trial Team. Bonnet M, et al. Among authors: laureillard d. Clin Infect Dis. 2023 Mar 8:ciad125. doi: 10.1093/cid/ciad125. Online ahead of print. Clin Infect Dis. 2023. PMID: 36883573

3

Effect of Tocilizumab on Mortality in Patients with SARS-CoV-2 Pneumonia Caused by Delta or Omicron Variants: A Propensity-Matched Analysis in Nimes University Hospital, France.

Laffont-Lozes P, Laureillard D, Loubet P, Stephan R, Chiaruzzi M, Clemmer E, Martin A, Roger C, Muller L, Claret PG, Goulabchand R, Roux C, Lavigne JP, Sotto A, Larcher R. Laffont-Lozes P, et al. Among authors: laureillard d. Antibiotics (Basel). 2023 Jan 4;12(1):88. doi: 10.3390/antibiotics12010088. Antibiotics (Basel). 2023. PMID: 36671288 Free PMC article.

4

Chemsex in HIV pre-exposure prophylaxis users: Assessment of mood disorders and addictive behavior.

Peyriere H, Jacquet JM, Peries M, Tribout V, Broche B, Mauboussin JM, Makinson A, Perrollaz C, Ferreyra M, Rouanet I, Montoya-Ferrer A, El-Majjaoui S, Corriol-Bonifas F, Fraisse T, Grau F, Laureillard D, Nagot N, Reynes J, Donnadieu-Rigole H. Peyriere H, et al. Among authors: laureillard d. Fundam Clin Pharmacol. 2023 Jun;37(3):639-649. doi: 10.1111/fcp.12854. Epub 2022 Dec 1. Fundam Clin Pharmacol. 2023. PMID: 36403123

5

Immunological and virological features of HIV-infected patients with increasing CD4 cell numbers despite virological failure during protease inhibitor-based therapy.

Weiss L, Burgard M, Cahen YD, Chaix ML, Laureillard D, Gilquin J, Piketty C, Viard JP, Kazatchkine MD, Girard PM, Rouzioux C. Weiss L, et al. Among authors: laureillard d. HIV Med. 2002 Jan;3(1):12-20. doi: 10.1046/j.1464-2662.2001.00095.x. HIV Med. 2002. PMID: 12059946 Free article.

6

Response to highly active antiretroviral therapy among severely immuno-compromised HIV-infected patients in Cambodia.

Madec Y, Laureillard D, Pinoges L, Fernandez M, Prak N, Ngeth C, Moeung S, Song S, Balkan S, Ferradini L, Quillet C, Fontanet A. Madec Y, et al. Among authors: laureillard d. AIDS. 2007 Jan 30;21(3):351-9. doi: 10.1097/QAD.0b013e328012c54f. AIDS. 2007. PMID: 17255742 Free article.

7

Prevalence, determinants of positivity, and clinical utility of cryptococcal antigenemia in Cambodian HIV-infected patients.

Micol R, Lortholary O, Sar B, Laureillard D, Ngeth C, Dousset JP, Chanroeun H, Ferradini L, Guerin PJ, Dromer F, Fontanet A. Micol R, et al. Among authors: laureillard d. J Acquir Immune Defic Syndr. 2007 Aug 15;45(5):555-9. doi: 10.1097/QAI.0b013e31811ed32c. J Acquir Immune Defic Syndr. 2007. PMID: 17577124

8

Positive outcomes of HAART at 24 months in HIV-infected patients in Cambodia.

Ferradini L, Laureillard D, Prak N, Ngeth C, Fernandez M, Pinoges L, Puertas G, Taburet AM, Ly N, Rouzioux C, Balkan S, Quillet C, Delfraissy JF. Ferradini L, et al. Among authors: laureillard d. AIDS. 2007 Nov 12;21(17):2293-301. doi: 10.1097/QAD.0b013e32828cc8b7. AIDS. 2007. PMID: 18090277

9

Drug resistance profiles for the HIV integrase gene in patients failing raltegravir salvage therapy.

Charpentier C, Karmochkine M, Laureillard D, Tisserand P, Bélec L, Weiss L, Si-Mohamed A, Piketty C. Charpentier C, et al. Among authors: laureillard d. HIV Med. 2008 Oct;9(9):765-70. doi: 10.1111/j.1468-1293.2008.00628.x. Epub 2008 Jul 21. HIV Med. 2008. PMID: 18651855 Free article.

10

Foscarnet salvage therapy efficacy is associated with the presence of thymidine-associated mutations (TAMs) in HIV-infected patients.

Charpentier C, Laureillard D, Sodqi M, Si-Mohamed A, Karmochkine M, Bélec L, Weiss L, Piketty C. Charpentier C, et al. Among authors: laureillard d. J Clin Virol. 2008 Oct;43(2):212-5. doi: 10.1016/j.jcv.2008.07.001. Epub 2008 Aug 28. J Clin Virol. 2008. PMID: 18760662

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

113 results

Search Page